Alyeska Investment Group
DPLO

Alyeska Investment Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Alyeska Investment Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-229,895
Closed -$1.34M – 550
2019
Q1 		$1.34M Buy
+229,895
New +$2.37M 0.02% 303
2018
Q2 		– Sell
-145,066
Closed -$2.92M – 571
2018
Q1 		$2.92M Buy
+145,066
New +$3.38M 0.02% 325
2015
Q2 		– Sell
-25,000
Closed -$865K – 601
2015
Q1 		$865K Buy
+25,000
New +$680K 0.01% 441

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alyeska Investment Group's DPLO Position: Q2 2019 in Review

Alyeska Investment Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 229,895 shares — an estimated $1.34M sold.

Alyeska Investment Group first reported a position in DPLO in Q1 2015 and held it in 3 quarters. The position peaked at $2.92M in Q1 2018. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • Alyeska Investment Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 229,895 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $1.34M.
  • Alyeska Investment Group first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2015 and held it in 3 quarters.
  • Alyeska Investment Group's DIPLOMAT PHARMACY, INC. position peaked at $2.92M in Q1 2018.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on Alyeska Investment Group's 13F filing for Q2 2019, filed 14 Aug 2019.